학술논문
1828P ARX517: A next generation anti-PSMA antibody drug conjugate (ADC) demonstrates notable stability and pharmacokinetic (PK) profile in the ARX517 phase I clinical trial (APEX-01)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S990-S990
Subject
Language
ISSN
0923-7534